期刊文献+

多发椎管内髓系肉瘤进展为急性髓系白血病伴t(8;21)异常1例并文献复习 被引量:3

下载PDF
导出
摘要 目的:提高对椎管内髓系肉瘤(MS)的诊断、治疗及预后的认识。方法:报告1例多发椎管内MS进展为急性髓系白血病(AML)伴t(8;21)异常患者,并就其临床特点、诊治过程及预后进行讨论。结果:病理及免疫组织化学支持MS诊断,骨髓染色体核型示46,X,-Y,t(8;21)(q22,q22)。结论:病理及免疫组织化学是确诊MS的主要手段,孤立性MS确诊前应重视行AML特异性融合基因和染色体核型检查。尽早联合化疗及异基因造血干细胞移植可能是治疗该病的理想策略。
作者 黄走方
出处 《赣南医学院学报》 2015年第1期126-127,130,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
  • 相关文献

参考文献10

  • 1Yilmaz AF,Saydam G,Sahin F.Granulocytic sarcoma:a systematic review[J].Am J Blood Res,2013,3(4):265-270.
  • 2李德志,孔德生,郝淑煜,刘东康,杨俊,王贵怀.2447例椎管内肿瘤的流行病学特点[J].中华神经外科杂志,2014,30(7):653-657. 被引量:25
  • 3Klco JM,Welch JS,Nquyen TT.State of the art in myeloid sarcoma[J].Int J Lab Hematol,2011,33(6):555-565.
  • 4Piler SA,Ascani S,Cox MC,et al.Myeloid sarcoma:clinico-pathologic,phenotypic and cytogenetic analysis of 92 adult patients[J].Leukemia,2007,21(2):340-350.
  • 5李吉满,刘卫平,张明虎,魏曦,古吉敏,韩爱军,吴文乔,陈心怡.髓系肉瘤的临床病理特征及免疫组织化学在其鉴别诊断中的作用[J].中华病理学杂志,2006,35(10):606-611. 被引量:81
  • 6余国攀,孟凡义,徐丹,周红升.椎管内粒细胞肉瘤6例[J].实用医学杂志,2011,27(23):4267-4268. 被引量:6
  • 7Marcucci G,Mrozek K,Ruppert AS,et al.Prognosic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21)differ from those of patients with inv(16):a Cancer and Leukemia Group B study[J].J Clin Oncol,2005,23(24):5705-5717.
  • 8Baskt RL,Tallman MS,Douer D,et al.How I treat extramedullary acute myeloid leukemia[J].Blood,2011,8(14):3785-3795.
  • 9Shimizu H,Saitoh T,Tanaka M,et al.Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma[J].Leukemia,2012,26(12):2469-2473.
  • 10Bakst R,Wolden S,Yahalom J.Radiation therapy for choroma[J].Int J Radiat Oncol,2012,82(5):1816-1822.

二级参考文献44

  • 1景治涛,罗世祺,甲戈,马振宇,张玉琪.儿童椎管内肿瘤(附151例临床分析)[J].中华神经外科杂志,2005,21(9):527-529. 被引量:12
  • 2Jee H S, Jeongmi P, Sun K K, et al. Granulocytic Sarcoma of the Spine: MRI and Clinical Review [J]. AJR, 2010,194: 485 -489.
  • 3Rubnitz J E, Raimondi S C, Halbert A R, et al. Characteristics and outcome of t (8;21)-positive childhood acute myeloid leukemia: A single institution's experience [J]. Leukemia, 2002, 16(10) : 2072-2077.
  • 4Lan T Y, Lin D T, Tien H F, et al. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma [J]. Acta Haematol, 2009,122(4) :238-246.
  • 5Marcucci G, Mrozek K, Ruppert A S, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t (8;21) differ from those of patients with inv (16): a Cancer and Leukemia Group B study [J]. J Clin Oncol, 2005,23 (24) : 5705-5717.
  • 6Chevallier P, Mohty M, Lioure B, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC [J]. J Clin Oncol, 2008, 26 (30) : 4940-4943.
  • 7Liu PI,Ishimaru T,McGregor DH,et al.Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia,Hiroshima-Nagasaki 1949-1969.Cancer,1973,31:948-955.
  • 8Krause JR.Granulocytic sarcoma preceding acute leukemia:a report of six cases.Cancer,1979,44:1017-1021.
  • 9Muss HB,Moloney WC.Chloroma and other myeloblastic tumors.Blood,1973,42:721-728.
  • 10Breccia M,Mandelli F,Petti MC,et al.Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up:report of 12 cases from a single institution.Leuk Res,2004,28:1165-1169.

共引文献107

同被引文献19

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部